5:42 PM
 | 
Mar 18, 2016
 |  BC Extra  |  Company News

Management tracks

Gene editing company CRISPR Therapeutics AG (Basel, Switzerland) named Marc Becker CFO. He was CFO and SVP at rEVO Biologics Inc. (Framingham, Mass.). CRISPR also named Tony Coles, the chairman and CEO of Yumanity Therapeutics LLC (Cambridge, Mass.), as its chairman.

Antibody play Kymab Ltd. (Cambridge, U.K.) named David Chiswell CEO, effective next month. He had been interim CEO since Christian Grondahl stepped down...

Read the full 323 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >